Post-surgical Treatment of Melanoma In Situ of the Vulva With Imiquimod

Journal of Obstetrics and Gynaecology Canada

Volumn 32, Issue 8, 2010, Pages 771-774

  Sadownik, Leslie A ^a   Crawford, Richard I ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Imiquimod; Melanoma in situ; Vulva

Indexed keywords

IMIQUIMOD; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CASE REPORT; FEMALE; GENITAL EDEMA; GENITAL ERYTHEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MELANOMA; MELANOMA IN SITU; MUCOSAL MELANOMA; POSTOPERATIVE CARE; PUNCH BIOPSY; SKIN FIBROSIS; TUMOR REGRESSION; VULVA CARCINOMA; WIDE EXCISION; MULTIMODALITY CANCER THERAPY; VULVA TUMOR;

AGED; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MELANOMA; VULVAR NEOPLASMS;

EID: 79957961458     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34619-9     Document Type: Article

References (14)

1. Kingston N.J., Jones R.W., Baranyai J. Recurrent primary vulvovaginal malignant melanoma arising in melanoma in situ-the natural history of lesions followed for 23 years. Int J Gynecol Cancer 2004, 14:628-632.
2. Sober A.J., Chuang T.Y., Duvic M., Farmer E.R., Grichnik J.M., Halpern A.C., et al. Guidelines/Outcomes Committee. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol 2001, 45:579-586.
3. Brandt S.E., Welvaart K., Hermans J. Is long-term follow-up justified after excision of a thin melanoma (less than or equal to 1.5 mm)? A retrospective analysis of 206 patients. J Surg Oncol 1990, 43:157-160.
4. Brand E., Fu Y.S., Lagasse L.D., Berek J.S. Vulvovaginal melanoma: report of seven cases and literature review. Gynecol Oncol 1989, 33:54-60.
5. Stanley M.A. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 2002, 27:571-577.
6. Navi D., Huntley A. Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatol Online J 2004, 10:4.
7. Todd R.W., Etherington I.J., Luesley D.M. The effects of 5% imiquimod cream on high-grade vulvar intraepithelial neoplasia. Gynecol Oncol 2002, 85:67-70.
8. Kim Y., Kim J., Koh B. Successful treatment of vulvar Bowen's disease with topical imiquimod 5% cream. Int J Derm 2006, 45:151-153.
9. Le T., Hicks W., Menard C., Hopkins L., Fung M.F. Preliminary results of 5% imiquimod cream in the primary treatment of vulvar intraepithelial neoplasia grade 2/3. Am J Obstet Gynecol 2006, 194:377-380.
10. Marchitelli C., Secco G., Perrotta M., Lugones L., Pesce R., Testa R. Treatment of bowenoid and basaloid vulvar intraepithelial neoplasia 2/3 with imiquimod 5% cream. J Reprod Med 2004, 49:876-882.
11. Wang L.C., Blanchard A., Judge D.E., Lorincz A.A., Medenica M.M., Busbey S. Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream. J Am Acad Dermatol 2003, 49:769-772.
12. Londsdale-Eccles A., Morgan J.M., Nagarajan S., Cruickshank D.J. Successful treatment of vulval melanoma in situ with topical 5% imiquimod cream. Br J Dermatol 2006, 155:215-217.
13. Fleming C.J., Bryden A.M., Evans A., Dawe R.S., Ibbotson S.H. A pilot study of treatment of lentigo maligna with 5% imiquimod cream. Br J Dermatol 2004, 151:485-488.
14. Rajpar S.F., Marsden J.R. Imiquimod in the treatment of lentigo maligna. Br J Dermatol 2006, 155:653-656.